Skip to main content
Premium Trial:

Request an Annual Quote

Syngewnta Donates Arabidopsis Seed Lines to Ohio State Center, Deposits Sequence Info in GenBank

NEW YORK, May 27 (GenomeWeb News) - Syngenta has donated 48,000 seed lines in its arabidopsis functional genomics seed collection to the Arabidopsis Biological Resource Center hosted at Ohio State University, the company said today.


The ARBC and the Nottingham Arabidopsis Stock Centre in Nottingham, UK will jointly distribute the seed lines to researchers.


The company is also depositing the sequence information from these seed lines into GenBank, and said the collection would be available to GenBank users "in late-May."


  "The donation contains novel seeds that we currently do not have in our collection. It will im­prove our understanding of how individual genes can influence a plant's growth," Randy Scholl, Director of the ABRC, said in a statement.

The ARBC, established in 1991 with a National Science Foundation grant, collects, preserves, and distributes Arabidopsisseeds and related plant materials.

This is not the first time Syngenta has made private sequence publicly available. In 2002, the company announced it had completed a draft sequence of the japonica rice genome, and would deposit this sequence information into GenBank once a more complete sequence was obtained.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.